AUSTRALIA'S #1 ONLINE CPD EDUCATION PLATFORM

Advertisement

Webinar: Diabetes treatment trials and tribulations: Overcoming therapeutic inertia

 


How can we encourage our patients to reach and maintain optimal glycaemic control in type 2 diabetes (T2D)? Often we need to rationalise what’s not working to be able to choose solutions that will work.

By understanding the phases and characteristics of diabetes therapeutic inertia, you will be able to identify where the road blocks are happening – whether it is your patient’s psychological insulin resistance, your own understandable concern about hypoglycaemia or a missing link in the multidisciplinary team.

Join this lively, interactive webinar, led by distinguished international and national experts and learn evidence-based solutions for diabetes treatment inertia to help you and your patients overcome this tricky issue!

Date and time: Wednesday 23 October 2019, 7:00 - 8:30pm (AEDT)

Cost: Free for ThinkGP users

Duration: 1.5 hours

Accreditation: Earn 3 RACGP QI&CPD or 2 ACRRM PDP points, reported directly to your college.

Learning objectives

By completing this learning activity, participants will be able to:

  • Discuss the positive effect of early glycaemic control on patient outcomes in type 2 diabetes
  • Identify the causes of therapeutic inertia in diabetes management
  • Rationalise the phases and characteristics of insulin inertia, including initiation, titration and intensification
  • Apply practical, evidence-based strategies to overcome therapeutic inertia in the Australian primary practice setting, including the role of new generation, co-formulation insulins

 

Already a ThinkGP member?

 

Not a ThinkGP member?

Create your free account to register for the webinar!

 

Presented by:

Professor Kamlesh Khunti

MD PhD FRCP FRCGP FMedSci

Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester, UK, and Co-Director of the Leicester Diabetes Centre. His work has influenced UK and international guidelines on the screening and management of people with diabetes

Dr Gary Deed

MBBS FACNEM MRACGP

Chair, RACGP Specific Interests Diabetes Network. GP, Brisbane and Clinical Chair of General practice management of type 2 diabetes 2016-2018 Australian guidelines

Margaret McGill

AM

Associate Professor at University of Sydney Central Clinical School, Faculty of Medicine and Health and Associate Director of the Royal Prince Alfred Hospital Diabetes Centre. Recognised global leader in the development of innovative clinical services for diabetes and medical and health professional education

 

 

   

 

Sponsored by

 

 

 

 

 

                                                                      

 

  • Discuss the positive effect of early glycaemic control on patient outcomes in type 2 diabetes
  • Identify the causes of therapeutic inertia in diabetes management
  • Rationalise the phases and characteristics of insulin inertia, including initiation, titration and intensification
  • Apply practical, evidence-based strategies to overcome therapeutic inertia in the Australian primary practice setting, including the role of new generation, co-formulation insulins